bullish
Ovctek China Inc (300595.CH) - Better See Some Potential Risks Before Making Decisions
210 Views30 Nov 2021 09:09
The insight mainly analyzed OVCTEK in terms of several potential risk points related to its business layout, development strategies,increasing competition,policy risks about qualifications and others.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
- China Healthcare Weekly (Jun.23) - National TCM VBP Results, CDE Changes Game Rule, Hua Medicine25 Jun 2023
- China Healthcare Weekly (Jun.16)- 9th National VBP Update, “Noise” of Consumption Upgrading, ChatGPT18 Jun 2023
- China Healthcare Weekly (May.26)- 9th National VBP, China's Strength in ADC Field, Ovctek, Eyebright28 May 2023
- Ovctek China Inc (300595.CH) - Better See Some Potential Risks Before Making Decisions30 Nov 2021
- 2022 High Conviction (China Healthcare) - Seek the Relative Certainties Out of the Uncertainties25 Nov 2021
- Eyebright Medical Technology (688050.CH) -The Impact Of Centralized Procurement and Business Outlook23 Nov 2021
- Investment Opportunities in China Medical Device Industry17 May 2021
x